U.S. Pharma Stock News

Centessa Pharmaceuticals recently reported past Phase II progress for its orexin agonist ORX750 in narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia, highlighting clinically meaningful effects alongside a favorable safety and tolerability profile. The company also outlined plans for registrational studies in rare hypersomnias, expanded its open-label extension to four weeks, and began preparing for regulatory engagement and commercial build-out, underscoring how central ORX750...

Reddit (NYSE:RDDT) has integrated with health marketing platform PulsePoint to give healthcare advertisers direct access to Reddit inventory. The partnership supports omnichannel healthcare campaigns that include Reddit alongside other digital media channels. Healthcare marketers can use PulsePoint's tools to plan, activate and measure targeted campaigns on Reddit. For Reddit, this move fits within its push to build out more specialized revenue streams from its large community and content...

Power Integrations (POWI) has drawn fresh attention after Director Balu Balakrishnan reported an automatic sale of 10,080 shares to cover tax from vested restricted stock, alongside mixed quarterly results and a 7% global workforce reduction. See our latest analysis for Power Integrations. The recent 3.95% 1 day share price return to US$46.85 and 25.44% 90 day share price return contrast with a 1 year total shareholder return decline of 15.64%, suggesting shorter term momentum has picked up...

On February 27, 2026, GEO Group’s Chief Financial Officer and Senior Vice President, Mark J. Suchinski, informed the company he would leave effective March 31, 2026, and GEO subsequently appointed long-time finance executive Shayn March as CFO and Senior Vice President, effective April 1, 2026. The transition places a 17-year GEO veteran with prior Acting CFO experience in charge of financial stewardship just as some institutional investors have exited amid concerns about the company’s...

If you are wondering whether MACOM Technology Solutions Holdings at around US$222.55 is still reasonably priced after its strong run, you are not alone. This article will focus on what that price might imply about value. The stock has seen a 6.9% decline over the past week and a 5.6% decline over the past month, yet it still sits on returns of 27.2% year to date and 108.0% over the past year, with a 224.5% return over three years and 233.3% over five years. Recent attention on the...

If you are wondering whether Scorpio Tankers at around US$73.26 still offers value after its strong run, this article will walk through what the current price could mean for long term investors. The stock has been volatile recently, with a 7 day return of an 8.6% decline, a 30 day return of 8.2%, and year to date and 1 year returns of 47.4% and 98.8% respectively. This shows that sentiment around the shares has clearly shifted over different time frames. Recent company specific news has kept...

Why Eos Energy Enterprises (EOSE) is in focus now Eos Energy Enterprises (EOSE) is back in the spotlight after reporting 2025 revenue of US$114.2 million, which was well below earlier guidance, and after facing multiple class action lawsuits tied to production issues and past disclosures. See our latest analysis for Eos Energy Enterprises. At a share price of US$6.45, Eos has had a very weak recent run, with a 1 month share price return of a 51.28% decline and a 3 month share price return of...

Netskope, Inc. has reported its fourth-quarter 2026 results, with sales of US$196.33 million and a net loss of US$56.77 million, and unveiled guidance for fiscal 2027 alongside the launch of its Netskope One AI Security suite. The introduction of Netskope One AI Security, which combines agentic AI protection, guardrails, gateways, and red teaming in a unified platform, positions the company directly in the emerging market for securing generative and enterprise AI use. We’ll now examine how...

Upcoming earnings as a potential catalyst Qfin Holdings (QFIN) has scheduled the release of its unaudited fourth quarter and full year 2025 results after U.S. markets close on March 17, 2026, followed by an earnings conference call. See our latest analysis for Qfin Holdings. Qfin Holdings' share price has come under pressure ahead of the earnings release, with a 1 day share price return of 2.20% decline, a 30 day share price return of 12.91% decline and a 1 year total shareholder return of...

Agilent Technologies (NYSE:A) has launched Agilent Advanced Therapeutics, a unified CDMO platform. The platform integrates BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to support end to end drug development and manufacturing. The move is aimed at offering biopharma customers a single partner from discovery through commercial scale production. Agilent Technologies, trading at $115.42, is adding a new CDMO platform on top of its existing life sciences tools and services. The...

Advance Auto Parts, Inc. recently appointed veteran retail and finance executive Cynthia Jamison as an independent director to its Board, while senior leaders prepared to speak at the UBS Global Consumer and Retail Conference in New York. Her extensive boardroom experience at companies like Darden Restaurants, Tractor Supply and Big Lots brings additional financial oversight and retail governance expertise at a time when Advance Auto Parts is working through a complex operational turnaround...

Atlantic Union Bankshares Corporation recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, drawing fresh attention from institutional investors. This event coincides with elevated call-option implied volatility and more optimistic analyst views, highlighting growing interest in the bank’s earnings outlook and risk profile. We’ll now examine how this heightened options activity and analyst optimism interact with Atlantic Union Bankshares’ existing...

Campbell's (CPB) has just reported its latest results with Q2 2026 revenue of US$2.68 billion and basic EPS of US$0.65, setting the tone for how the rest of the year may shape up. Looking back over recent quarters, revenue has moved between US$2.29 billion in Q4 2024 and US$2.77 billion in Q1 2025, while basic EPS has ranged from a small loss of US$0.01 in Q4 2024 to US$0.73 in Q1 2025. This gives investors a clear view of how sales and earnings have tracked into this quarter. With net income...

Conference spotlight and why AIRO is on more investor radars AIRO Group Holdings (AIRO) is set to present at the 2026 Cantor Global Technology & Industrial Growth Conference on March 11 in New York, giving investors a closer look at its aerospace and defense business. With Co Founder and Executive Chairman Chirinjeev Baboo Kathuria, Chief Executive Officer Joe Burns and Chief Financial Officer Mariya Pylypiv on stage, the session could offer more detail on AIRO’s drone, avionics, training and...

Prudential Financial (PRU) is back in focus after the board appointed CEO Andrew Sullivan as chairman, while former executive chairman Charles Lowrey transitions to a senior advisor role ahead of his planned retirement. See our latest analysis for Prudential Financial. The leadership change comes after a weaker patch for the shares, with a 90 day share price return of an 18.89% decline and a 1 year total shareholder return of a 5.74% decline, contrasting with a 37.66% gain over three years as...

Are you wondering whether Westlake's current share price reflects its true worth, or if the market is missing something important about this chemicals producer's future potential? Recently, the stock closed at US$107.03, with returns of 0.8% over 7 days, 10.9% over 30 days, 44.3% year to date, and 2.8% over the past year. These figures may have changed how some investors think about its risk and reward profile. Recent coverage of Westlake has focused on its position in basic materials and...

ARMOUR Residential REIT (ARR) is back in focus after reporting Q4 fiscal 2025 GAAP net income of $208.7 million, fresh capital raised through stock issuances, and management reaffirming confidence in its dividend outlook. See our latest analysis for ARMOUR Residential REIT. The Q4 results and fresh equity raise come after a period of mixed momentum, with ARMOUR Residential REIT’s recent 90 day share price return of 5.25% contrasting with a 5 year total shareholder return decline of 34.85%,...

Technical signal and earnings expectations shift focus to Globus Medical A recent hammer chart pattern in Globus Medical (GMED) has coincided with higher earnings estimates and a top Zacks Rank, prompting investors to reassess the spine and orthopedics specialist’s current share performance. See our latest analysis for Globus Medical. At a share price of US$87.17, Globus Medical has seen short term share price weakness with a 7 day return of 3.64% and a 90 day return of 1.92% decline, while...

If you are wondering whether Paychex is starting to look interesting at current levels, you are not alone. This article is built to help you weigh up what you are really paying for. The stock last closed at US$94.00, with returns of a 1.9% decline over 7 days, a 4.2% decline over 30 days, a 13.4% decline year to date and a 32.9% decline over 1 year, while the 3 year and 5 year returns sit at a 3.4% decline and 10.8% respectively. Recent market updates around Paychex have kept investors...

In early March 2026, Leidos Holdings announced a US$454.9 million contract to modernize the U.S. Air Force’s Cloud One multi-cloud platform, alongside a partnership and investment in Dropzone AI to bring agentic cybersecurity capabilities into highly regulated federal environments. Together, these moves highlight Leidos’ expanding role at the intersection of defense cloud modernization and AI-driven cyber defense for government customers. We’ll now examine how this large Air Force cloud...

Invesco (IVZ) has reported a 1.2% monthly increase in assets under management to US$2.26 billion, supported by US$4.7 billion in net long-term inflows and US$13.5 billion into money market products. See our latest analysis for Invesco. Recent product launches, including the Invesco Core Plus Real Estate Trust and several income focused ETFs, arrive as the 30 day share price return of Invesco shows an 10.9% decline while the 1 year total shareholder return sits at 63.5%. Long term holders have...

If you are wondering whether Opera's share price really reflects what the business is worth, you are not alone. This article is written with that exact question in mind. Over the short term the stock has seen mixed moves, with a 0.1% decline over the last 7 days, a 16.2% gain over 30 days, a 6.0% return year to date, an 11.3% decline over 1 year, and a 102.9% gain over 3 years, compared to a 57.8% return over 5 years. Recently, investors have been reacting to a series of Opera-focused...

Utz Brands (NYSE:UTZ) presented new protein-enriched snacks and globally inspired flavors at Natural Products Expo West. The lineup includes Boulder Canyon Agave Sriracha kettle chips and a high protein snack range with gluten free, non GMO, and kosher options. The launch targets growing interest in snacks that combine higher protein content with bolder, globally influenced taste profiles. For investors watching NYSE:UTZ, the new products come at a time when the share price is around $7.52,...

Recent analyst reports on Artivion (AORT) have zeroed in on the company’s aortic disease pipeline, with particular attention on the NEXUS stent graft system and its one year trial results, which show strong sealing and low complication rates. See our latest analysis for Artivion. Artivion’s share price has eased back recently, with a 30 day share price return of 8.23% and a 90 day share price return of 20.07% from a last close of US$36.35. However, the 1 year total shareholder return of...